LQDA 11.43 Liquidia Corporation
| Range: | 5.71-16.99 | Vol Avg: | 1298015 | Last Div: | 0 | Changes: | 0.05 |
| Beta: | 0.22 | Cap: | 0.92B | Currency: | USD | Exchange: | NASDAQ |
| Sector: | Healthcare | IPO: | Thu Jul 26 2018 | Empoloyees: | 145 | ||
| CUSIP: | 53635D202 | CIK: | 0001819576 | ISIN: | US53635D2027 | Country: | US |
| CEO: | Dr. Roger A. Jeffs Ph.D. | Website: | https://www.liquidia.com | ||||
Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension. It also distributes generic treprostinil injection in the United States. Liquidia Corporation was founded in 2004 and is headquartered in Morrisville, North Carolina.
Stock Details
About The Monevue
The content provided on this site is for informational purposes only and does not constitute financial, investment, or professional advice. We are not registered investment advisors or financial planners, and we do not provide recommendations or advice on buying, selling, or holding any particular stocks or securities. Any investment decisions should be made based on your own research and consultation with a qualified financial professional. We are not responsible for any financial loss or damages incurred from reliance on the information provided on this site. Please invest responsibly and seek professional advice when needed.
• Powered by StackThrow